New Front-Runner Emerges In China mRNA Booster Race

CSPC Reveals Promising Results

China domestic frontrunner mRNA vaccine
CSPC progressing domestic and international multicenter clinical studies of SYS6006. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from China

More from Focus On Asia